Article
The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement.
Thrombosis and haemostasis - 1 May 2006
Herman Darja, Peternel Polona, Stegnar Mojca, Breskvar Katja, Dolzan Vita
Abstract excerpt
The degree of interpatient variability in the warfarin dose required to achieve the desired anticoagulant response can only partly be explained by polymorphisms in the CYP2C9 gene, suggesting that additional genetic factors such as polymorphisms in genes involved in blood coagulation may influence warfarin dose requirement. In total, 165 Caucasian outpatients on stable maintenance warfarin treatment previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
